Lawsuits Allege Actos® Drug Linked to Increased Bladder Cancer Risk
Climaco, Wilcox, Peca, Tarantino & Garofoli Co., L.P.A. has filed several lawsuits against the manufacturer of Actos®. Actos® is a prescription medication used to treat type II diabetes. The FDA recently issued a safety alert to the public indicating that the use of Actos® for more than one year may increase the risk of developing bladder cancer. Cleveland, Ohio (PRWEB) October 15, 2011 Climaco, Wilcox, Peca, Tarantino & Garofoli Co., L.P.A. has filed several lawsuits against Takeda Pharmaceuticals, the manufacturer of the diabetes medication Actos® (pioglitazon
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4